We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New Zealand’s Medsafe has granted provisional approval for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, for active immunisation to prevent Covid-19 in individuals aged 18 years and above.